Oliver Luxxe Assets LLC Invests $1.69 Million in Innoviva

Institutional investor takes stake in biotechnology company

Mar. 22, 2026 at 10:42am by Ben Kaplan

Got story updates? Submit your updates here. ›

Oliver Luxxe Assets LLC acquired a new stake in Innoviva, Inc. (NASDAQ:INVA) during the 4th quarter, according to a recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 84,671 shares of the biotechnology company's stock, valued at approximately $1,693,000.

Why it matters

This investment highlights continued institutional interest in Innoviva, a biotechnology company focused on respiratory therapies. The stock has seen fluctuations in the past year, and this new stake from Oliver Luxxe Assets could signal confidence in the company's future prospects.

The details

Oliver Luxxe Assets LLC acquired the new stake in Innoviva, representing 0.11% ownership of the company. Several other hedge funds and institutional investors also made changes to their Innoviva holdings during the quarter, including increases by Creative Planning, Verition Fund Management LLC, and the Oregon Public Employees Retirement Fund.

  • The new stake was acquired during the 4th quarter of 2025.

The players

Oliver Luxxe Assets LLC

An institutional investor that acquired a new stake in Innoviva, Inc.

Innoviva, Inc.

A biotechnology company focused on respiratory therapies, whose stock was purchased by Oliver Luxxe Assets LLC.

Got photos? Submit your photos here. ›

The takeaway

This investment by Oliver Luxxe Assets LLC signals continued institutional interest in Innoviva, a biotechnology company with a focus on respiratory treatments. The stock has seen volatility, and this new stake could indicate confidence in the company's future prospects.